Choroid Plexus Disorder Treatment Market

Choroid Plexus Disorder Treatment Market Study by Ifosfamide, Carboplatin, Etoposide, Bevacizumab, Rapamycin, Cyclophosphamide for Choroid Plexus Tumors, and Low CSF from 2024 to 2034

Analysis of Choroid Plexus Disorder Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Choroid Plexus Disorder Treatment Market Outlook (2024 to 2034)

The global choroid plexus disorder treatment market size is projected to increase from US$ 130.2 million in 2024 to US$ 262.3 million by the end of 2034. As per Fact.MR’s new industry analysis, the market has been forecasted to expand at a CAGR of 7.3% from 2024 to 2034.

Choroid plexus disorder is the tumor formation in the primary central nervous system (CNS). Tumor formation begins in the brain or spinal cord. Choroid plexus cancer is a rare genetic disease. Cerebrospinal fluid (CSF) analysis technology is used to detect signs of choroid plexus disorder. People living with choroid plexus disorder may also have hydrocephalus. Nausea, vomiting, irritability, tremendous headaches, blurred or double vision, sleepiness, and seizures are some of the symptoms of hydrocephalus. The two types of choroid plexus tumors are choroid plexus papillomas (noncancerous). Growth of the former is slow while that of the latter sees aggressive growth.

  • Demand for choroid plexus papilloma (CPP) solutions is projected to increase at a CAGR of 7.4% through 2034.
  • According to the 'Diagnosis of choroid plexus papilloma: Current perspectives and future directions' article published by ScienceDirect, prevalence of choroid plexus papilloma is 10% to 20% in children below 1 year of age.

Prompt surgical resection is one option for the treatment of choroid plexus papilloma. Technological advancements in radiographic imaging, operating microscopy, surgical approaches, and quality of intensive care are set to improve surgical outcomes and lead to better long-term cure rates.

Report Attribute Detail
Choroid Plexus Disorder Treatment Market Size (2024E) US$ 130.2 Million
Forecasted Market Value (2034F) US$ 262.3 Million
Global Market Growth Rate (2024 to 2034) 7.3% CAGR
East Asia Market Value (2034F) US$ 21.3 Million
South Asia & Pacific Market Growth Rate (2024 to 2034) 9% CAGR
Key Companies Profiled Celon Laboratories Ltd.; Cipla Ltd.; Gls Pharma Pvt. Ltd.; Zydus Cadila; Bristol-Myers Squibb; Fresenius Kabi; Pfizer; Sun Pharmaceuticals; Natco Pharma; Celltrion Healthcare; Genentech USA; Amgen Inc.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

How are Choroid Plexus Disorder Treatment Solutions Advancing?

“Advancements in Radiation Therapies and Imaging Technologies Leading to Improved Treatment Outcomes”

Radiation therapy is one of the key treatments for choroid plexus disorder and recurrent brain tumors. Radiation therapy targets and destroys cancerous cells while minimizing the damage to the surrounding healthy cells. Radiation therapy can be applied alone or in combination with chemotherapy or surgery. External beam radiation therapy (EBRT) and brachytherapy are the most used radiation therapies for the treatment of brain tumors such as choroid plexus.

Advancements in radiation therapy such as modulated radiation therapy and stereotactic body radiation therapy (SBRT) are some of the latest choroid plexus disorder treatment market trends. These advancements are expected to boost the efficiency of results and reduce the side effects related to brain cancer.

Technological advancements have led to the development of high-resolution imaging technologies such as magnetic resonance imaging (MRI), and computed tomography (CT) scans. These advanced imaging technologies provide detailed images of the brain and spinal cord. This further allows clinicians to locate and characterize the choroid plexus tumors accurately. This precision helps doctors determine effective treatment methods to cure cancer.

Which Factors are Limiting Adoption of Choroid Plexus Disorder Solutions?

“High Cost of Treatment and Limited Research & Development Conducted”

The treatment procedure for choroid plexus disorders, especially specialized therapies or surgical interventions, is quite expensive. High cost of treatment poses a financial barrier to patients with low spending power. As such, patients with low incomes shy away from opting for cancer treatment procedures.

Furthermore, research on choroid plexus disorders is also relatively less than other neurological disorders. This further leads to a scarcity of innovative treatments and therapies, slowing down overall choroid plexus disorder treatment market growth.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Which Tactics are Helping New Companies Stand Apart from the Crowd?

“Focus on Innovations and Personalized Therapy Solutions”

New companies entering the choroid plexus disorder treatment market should focus on developing innovative and novel therapeutic technologies and approaches such as gene therapies and drug delivery systems. This could help them to differentiate from others. Furthermore, they should also focus on developing personalized treatment solutions based on the genetic and molecular characteristics of patients. This approach can enhance treatment efficacy and minimize adverse effects.

Country-wise Analysis

The United States is expected to hold 86.6% of the North American choroid plexus disorder treatment market share in 2024.

The United States is at the forefront of innovations and the adoption of the latest medical technologies. This factor has made the country the most profitable market for anticancer drug and therapy producers. Choroid plexus disorder therapeutic solutions are also expected to exhibit healthy demand growth in South Korea and Japan. Investments in cancer research are expected to drive the market growth in these countries.

Which Factors are Driving Demand for Choroid Plexus Therapeutic Solutions in the United States?

“Presence of Advanced Healthcare Infrastructure and High Investments in Research Funding”

Attribute United States
Market Value (2024E) US$ 57.6 Million
Growth Rate (2024 to 2034) 8% CAGR
Projected Value (2034F) US$ 124.2 Million

The United States boasts an advanced healthcare infrastructure with the presence of cutting-edge medical facilities, advanced diagnostic technologies, and skilled medical professionals. This aids in early detection, accurate diagnostics, and effective treatment for cancer including choroid plexus.

The government is investing heavily in biomedical research. This funding is supporting the cancer research and development of novel therapeutic approaches. Thus, research grants also aid scientists and clinicians in exploring innovative drug and surgical solutions for cancer including choroid plexus.

What is the Demand Outlook for Choroid Plexus Disorder Treatment Approaches in Japan?

“Strong Presence of Geriatric Population More Prone of Cancer Disorders”

Attribute Japan
Market Value (2024E) US$ 3.1 Million
Growth Rate (2024 to 2034) 3.1% CAGR
Projected Value (2034F) US$ 4.2 Million
  • Approximately 29.9% out of the total Japanese population was 65 years of age or older in Japan in 2022, and by 2070 this is expected to rise by 38%, according to Statista.

Japan has one of the world’s oldest populations, with a substantial proportion over the age of 65. Older people are more prone to chronic disorders including cancer and neurological diseases. This is expected to drive the demand for choroid plexus disorder therapeutic solutions.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Analysis

Which Age Group is More Affected by Choroid Plexus Disorders?

“Higher Prevalence of Choroid Plexus Disorders among Children”

Attribute Children
Segment Value (2024E) US$ 63.6 Million
Growth Rate (2024 to 2034) 7.4% CAGR
Projected Value (2034F) US$ 129.8 Million
  • According to the National Center of Biotechnology Information, choroid plexus disorder predominantly attacks children and approximately 70% of choroid plexus papillomas are diagnosed before 2 years of age.

Choroid plexus papillomas are benign tumors and typically occur in the supratentorial compartment of the brain in children. Hydrocephalus is a common consequence of choroid plexus disorders where CSF accumulates in the brain’s verticle, causing pressure on brain tissues. If not treated, this can lead to developmental delay and neurological deficits. Thus, timely diagnosis and treatment of choroid plexus disorder is extremely necessary in children.

Which is the Prime Distribution Channel for Choroid Plexus Disorder Medications?

“Hospital Pharmacies Equipped with Specialized Medications Hold Leading Market Share”

Attribute Hospital Pharmacies
Segment Value (2024E) US$ 80 Million
Growth Rate (2024 to 2034) 7.4% CAGR
Projected Value (2034F) US$ 162.8 Million

Choroid plexus disorders require specialized medications that are not easily available at retail pharmacies. Hospital pharmacies are stocked with specialized pharmaceuticals. These include compounded formulations, medications with specific storage and handling requirements, and intravenous medications.

Hospital pharmacies are also staffed with skilled pharmacists and technicians who have taken specialized training and have experience in managing complex medical conditions. They ensure that patients receive the appropriate medications and dosages as per their needs. These factors make them the leading distribution channel for cancer medications, including choroid plexus.

Business Landscape

Key players in the choroid plexus disorder treatment market are resorting to several organic and inorganic tactics such as product innovations, strategic partnerships, mergers & acquisitions, and competitive pricing to reach a wider consumer base and earn high profits.

Leading companies are also collaborating with academic and research institutions to develop novel therapeutic approaches. They are building relationships with healthcare providers such as neurologists, surgeons, and pediatricians to increase their brand visibility.

  • According to a research article published by Sage Journals in February 2024, longitudinal enlargement of choroid plexus is associated with chronic lesion expansion and neurodegeneration in relapsing-remitting multiple sclerosis (RRMS) patients.
  • In May 2023, Northwestern Medicine researchers reported the breakthrough results of the first human clinical trial where they used an innovative, skull-implantable ultrasound device that opens the blood-brain barrier to treat brain cancer.

Fact.MR provides detailed information about the price points of key producers of choroid plexus disorder treatment solutions positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.

Key Segments of Choroid Plexus Disorder Treatment Market Research

  • By Indication :

    • Choroid Plexus Tumors
    • Choroid Plexus Papillomas
    • Low CSF (Hydrocephalus)
  • By Treatment :

    • Ifosfamide
    • Carboplatin
    • Etoposide
    • Bevacizumab
    • Rapamycin
    • Cyclophosphamide
    • Others
  • By Age Group :

    • Infants/Pediatric
    • Children
    • Adults
    • Geriatric
  • By Distribution Channel :

    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
  • By Region :

    • North America
    • Latin America
    • Western Europe
    • Eastern Europe
    • East Asia
    • South Asia & Pacific
    • Middle East & Africa

- FAQs -

How big is the choroid plexus disorder treatment market size in 2024?

The global choroid plexus disorder treatment market is estimated at US$ 130.2 million in 2024.

What is the projected valuation of the global market for 2034?

The market for choroid plexus disorder treatment is forecasted to reach US$ 262.3 million by 2034.

What is the estimated growth of the choroid plexus disorder treatment market?

The global market is forecasted to register a CAGR of 7.3% through 2034.

Which is a key regional market for choroid plexus disorder treatment?

The North American market is approximated at a value of US$ 66.5 million in 2024.

Who are the top choroid plexus disorder solution companies?

Some of the key market players are Cipla Ltd., Bristol-Myers Squibb, Fresenius Kabi, Gls Pharma Pvt. Ltd., Zydus Cadila, and Pfizer.

What is the future of choroid plexus disorder treatment solutions in South Korea?

Demand for choroid plexus disorder treatment in South Korea is forecasted to increase at a CAGR of 8.1% from 2024 to 2034.

Which is the most prevalent type of choroid plexus disorder?

Choroid plexus papilloma is one of the most prevalent cancer types and is expected to hold 47.9% market share in 2024.

- Also of Interest -

Cancer Profiling Market

Cancer Profiling Market By Product (Instruments, Consumables), By Indication (Breast, Colorectal, Ovarian, Melanoma, Kidney, Lung and Rare Cancer), By End User, By Test Cancer, By Region - Global Market Insights 2021 to 2031

Cancer Immunotherapy Market

Cancer Immunotherapy Market Study by Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, and Cancer Immunotherapy Vaccines from 2024 to 2034

Anti-cancer Drugs Market

Anti-cancer Drugs Market Analysis by Cytotoxics, Hormonal Therapy, and Targeted Therapy for Prostate Cancer, Lung Cancer, Breast Cancer, Melanoma, and Colon & Rectum Cancer from 2024 to 2034

Cancer Biomarkers Market

Cancer Biomarkers Market Analysis by Test Type (PSA Tests CTC Tests, AFP Tests, CA Tests, HER2 Tests, BRCA Tests, ALK Tests, KRAS Mutation Tests), by Illness Indication (Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer), by Region - Global Insights 2022-2032

Choroid Plexus Disorder Treatment Market

Schedule a Call